Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Andexxa (coagulation factor Xa recombinant, inactivated-zhzo) for the Treatment of Factor Xa Inhibitor-Associated Acute Major Bleeding

Drug Name

Andexxa®

Developed By

Portola Pharmaceuticals

Therapy Class

Anti-thrombotic

Current Indication

Factor Xa inhibitor-associated acute major bleeding

Market Sector

Cardiovascular

Development Status

Approved in the US
Expand

Go Top